# Activation of NOD2 Receptors in Preterm Infants by Lactobacillus Reuteri DSM17938

> **NCT06782061** · NA · COMPLETED · sponsor: **Nanfang Hospital, Southern Medical University** · enrollment: 15 (actual)

## Conditions studied

- Preterm Infants

## Interventions

- **OTHER:** DSM17938+Routine clinical treatment

## Key facts

- **NCT ID:** NCT06782061
- **Lead sponsor:** Nanfang Hospital, Southern Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-12-26
- **Primary completion:** 2025-01-19
- **Final completion:** 2025-01-19
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2025-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06782061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06782061, "Activation of NOD2 Receptors in Preterm Infants by Lactobacillus Reuteri DSM17938". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06782061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*